35
Views
0
CrossRef citations to date
0
Altmetric
Review

Utilizing enoxaparin in the management of STEMI

, &
Pages 691-700 | Published online: 28 Dec 2022

References

  • AntmanEMThe search for replacements for unfractionated heparinCirculation20011032310411342482
  • AntmanEMMcCabeCHGurfinkelEPEnoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction: results of the Thrombolysis In Myocardial Infarction (TIMI) 11B trialCirculation1999100159360110517729
  • AntmanEMLouwerenburgHWBaarsHFEnoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction. Results of the ENTIRE-Thrombolysis In Myocardial Infarction (TIMI) 23 TrialCirculation20021051642911940541
  • AntmanEMAnbeDTArmstrongPWACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary and recommendation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelinesCirculation200411058863615289388
  • AntmanEMMorrowDAMcCabeCHEnoxaparin versus unfractionated heparin with thrombolysis for ST-elevation myocardial infarctionN Engl J Med200635414778816537665
  • [ASSENT] Assessment of the Safety and Efficacy of a New Thrombolytic regimen (ASSENT)-3 investigatorsEfficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractioned heparin: the ASSENT-3 randomised trial in acute myocardial infarctionLancet20013586051311530146
  • BairdSHMenownIBAMcBrideSJRandomized comparison of enoxaparin with unfractioned heparin following fibrinolytic therapy for acute myocardial infarctionEur Heart J2002236273211969277
  • BertrandMESimoonsMLFoxKAAManagement of acute coronary syndromes in patients presenting without persistent ST-segment elevationEur Heart J20022318094012503543
  • BraunwaldEAntmanEMBeasleyJWACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the management of patients with unstable angina)J Am Coll Cardiol20024013667412383588
  • CohenMDemersCGurfinkelEPfor the Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-wave Coronary Events study groupA comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery diseaseN Engl J Med1997337447529250846
  • EikelboomJWQuinlanDJMehtaSRUnfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction. A meta-analysis of the randomized trialsCirculation200511238556716344381
  • GlickAKornowskiRMichowichYReduction of reinfarction and angina with use of low-molecular-weight heparin therapy after streptokinase (and heparin) in acute myocardial infarctionAm J Cardiol199677114588651085
  • HirshJAnandSSHalperinJLGuide to anticoagulant therapy: heparin. A statement for healthcare professionals from the American Heart AssociationCirculation20011032994301811413093
  • RossAMMolhoekPLunderganCRandomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractioned heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin. Second trial of Heparin and Aspirin Reperfusion Therapy (HART-II)Circulation20011046485211489769
  • SimoonsMLKrzeminska-PakulaMAlonsoAImproved reperfusion and clinical outcome with enoxaparin as an adjunct to streptokinase thrombolysis in acute myocardial infarction. The AMI-SK StudyEur Heart J20022312829012175665
  • Tatu-ChitoiuGTeodorescuCCapraruPAccelerated streptokinase and enoxaparin in ST-segment elevation acute myocardial infarction (the ASENOX study)Pol Heart J2004604416
  • Van de WerfFArdissinoDBetriuAManagement of acute myocardial infarction in patients presenting with ST-segment elevationEur Heart J200324286612559937
  • WallentinLGoldsteinPArmstrongPWEfficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting. The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarctionCirculation20031081354212847070

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.